IDI1 inhibitors belong to a specific chemical class known for their capacity to modulate the activity of IDI1 enzymes. IDI1, or Isopentenyl-diphosphate Delta-isomerase 1, is a critical enzyme involved in the mevalonate pathway, a fundamental metabolic route responsible for the biosynthesis of isoprenoids. Isoprenoids, including molecules like cholesterol and certain hormones, play essential roles in various cellular processes, such as membrane structure, cell signaling, and protein modifications. IDI1 inhibitors act by binding to distinct regions within the enzyme's active site, thereby disrupting its normal catalytic function. As a result, these inhibitors can influence the flux of isoprenoid biosynthesis within the cell.
The class of IDI1 inhibitors encompasses a diverse range of chemical compounds, each designed to interact with the enzyme in a specific manner. Researchers have undertaken extensive efforts to uncover the structural features and molecular interactions that govern the inhibitory activity of these compounds. Through this exploration, they aim to gain valuable insights into the intricate regulation of the mevalonate pathway and its impact on the cellular synthesis of isoprenoids. The study of IDI1 inhibitors is a compelling area of research in the fields of biochemistry and chemical biology. By elucidating the mechanisms of IDI1 inhibition, scientists can deepen their understanding of cellular metabolism and the interplay between various enzymatic pathways. Furthermore, exploring the impact of IDI1 inhibitors on isoprenoid biosynthesis provides critical information about the broader roles of these molecules in cellular function and physiology.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IPI 145 | 1201438-56-3 | sc-488318 | 5 mg | $317.00 | ||
Although primarily known as an inhibitor of PI3K-δ and PI3K-γ, IPI-145 has been reported to have some inhibitory activity against IDI1, potentially impacting isoprenoid biosynthesis. | ||||||
Fluvastatin, Sodium Salt | 93957-55-2 | sc-202613 sc-202613A sc-202613B | 25 mg 50 mg 100 mg | $93.00 $138.00 $246.00 | 1 | |
Statins, such as fluvastatin, are known to inhibit the enzyme HMG-CoA reductase, which is upstream of IDI1 in the mevalonate pathway. By reducing the production of mevalonate, statins indirectly affect IDI1 activity and isoprenoid synthesis. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $92.00 $256.00 | 5 | |
Zoledronic acid is a bisphosphonate agent in research used for bone-related conditions. It indirectly inhibits IDI1 by disrupting the mevalonate pathway. | ||||||
Neridronate | 79778-41-9 | sc-253184 | 10 mg | $95.00 | ||
Neridronate is another bisphosphonate that indirectly affects IDI1 activity by interfering with the mevalonate pathway. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $143.00 $510.00 | 2 | |
U18666A is an experimental compound known to inhibit cholesterol transport and metabolism, potentially impacting the mevalonate pathway and IDI1. | ||||||
Farnesyl thiosalicylic acid | 162520-00-5 | sc-205322 sc-205322A | 1 mg 5 mg | $61.00 $82.00 | 15 | |
This compound has been studied for its potential to inhibit various enzymes involved in isoprenoid biosynthesis, including IDI1. | ||||||